These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
160 related articles for article (PubMed ID: 38363600)
1. Clinicopathological analysis of 38 male patients diagnosed with breast cancer. Sahin SI; Balci S; Guler G; Altundag K Breast Dis; 2024; 43(1):1-8. PubMed ID: 38363600 [TBL] [Abstract][Full Text] [Related]
2. [Clinicopathological features and prognostic factors of breast cancer patients with inguinal lymph node metastases: a report of 17 cases]. Li Q; Xu BH; Zhang P; Li Q; Yuan P; Wang JY; Luo Y; Ma F; Fan Y; Li Q Zhonghua Zhong Liu Za Zhi; 2013 Mar; 35(3):207-11. PubMed ID: 23880002 [TBL] [Abstract][Full Text] [Related]
3. Breast Cancer in Men: a Report from the Department of Radiation Oncology in Kermanshah Province, Iran. Amirifard N; Sadeghi E Asian Pac J Cancer Prev; 2016; 17(5):2593-6. PubMed ID: 27268636 [TBL] [Abstract][Full Text] [Related]
4. Steroid receptor status and its clinicopathological correlation in post-menopausal breast cancer patients of Kumaon region of Uttarakhand. Shahi KS; Bhandari G; Singh A J Cancer Res Ther; 2011; 7(1):19-22. PubMed ID: 21546737 [TBL] [Abstract][Full Text] [Related]
5. Characterization and prognosis of estrogen receptor-positive/progesterone receptor-negative male breast cancer: a population-based study. Wei JL; Zhang JX; Fu DY World J Surg Oncol; 2018 Dec; 16(1):236. PubMed ID: 30558615 [TBL] [Abstract][Full Text] [Related]
6. Outcome of non-metastatic male breast cancer: 118 patients. Arslan UY; Oksüzoğlu B; Ozdemir N; Aksoy S; Alkış N; Gök A; Kaplan MA; Gümüş M; Berk V; Uncu D; Baykara M; Colak D; Uyetürk U; Türker I; Işıkdoğan A Med Oncol; 2012 Jun; 29(2):554-60. PubMed ID: 21573973 [TBL] [Abstract][Full Text] [Related]
7. Metaplastic breast cancer: clinicopathological features and its prognosis. Lee H; Jung SY; Ro JY; Kwon Y; Sohn JH; Park IH; Lee KS; Lee S; Kim SW; Kang HS; Ko KL; Ro J J Clin Pathol; 2012 May; 65(5):441-6. PubMed ID: 22412048 [TBL] [Abstract][Full Text] [Related]
8. Invasive micropapillary carcinoma of the breast: high incidence of lymph node metastasis with extranodal extension and its immunohistochemical profile compared with invasive ductal carcinoma. Zekioglu O; Erhan Y; Ciris M; Bayramoglu H; Ozdemir N Histopathology; 2004 Jan; 44(1):18-23. PubMed ID: 14717664 [TBL] [Abstract][Full Text] [Related]
9. Tumor Budding is a reliable predictor for death and metastasis in invasive ductal breast cancer and correlates with other prognostic clinicopathological parameters. Okcu O; Öztürk Ç; Şen B; Arpa M; Bedir R Ann Diagn Pathol; 2021 Oct; 54():151792. PubMed ID: 34293708 [TBL] [Abstract][Full Text] [Related]
10. Comparison of ER, PR and HER-2/neu (C-erb B 2) reactivity pattern with histologic grade, tumor size and lymph node status in breast cancer. Azizun-Nisa ; Bhurgri Y; Raza F; Kayani N Asian Pac J Cancer Prev; 2008; 9(4):553-6. PubMed ID: 19256737 [TBL] [Abstract][Full Text] [Related]
11. Clinicopathological and Immunohistochemical Characteristics in Male Breast Cancer: A Retrospective Case Series. Masci G; Caruso M; Caruso F; Salvini P; Carnaghi C; Giordano L; Miserocchi V; Losurdo A; Zuradelli M; Torrisi R; Di Tommaso L; Tinterri C; Testori A; Garcia-Etienne CA; Gatzemeier W; Santoro A Oncologist; 2015 Jun; 20(6):586-92. PubMed ID: 25948676 [TBL] [Abstract][Full Text] [Related]
12. Comparative prognostic analysis for triple-negative breast cancer with metaplastic and invasive ductal carcinoma. Li Y; Zhang N; Zhang H; Yang Q J Clin Pathol; 2019 Jun; 72(6):418-424. PubMed ID: 30872384 [TBL] [Abstract][Full Text] [Related]
13. Worse prognosis of metaplastic breast cancer patients than other patients with triple-negative breast cancer. Jung SY; Kim HY; Nam BH; Min SY; Lee SJ; Park C; Kwon Y; Kim EA; Ko KL; Shin KH; Lee KS; Park IH; Lee S; Kim SW; Kang HS; Ro J Breast Cancer Res Treat; 2010 Apr; 120(3):627-37. PubMed ID: 20143153 [TBL] [Abstract][Full Text] [Related]
14. Clinicopathological characteristics of male breast cancer. Park S; Kim JH; Koo J; Park BW; Lee KS Yonsei Med J; 2008 Dec; 49(6):978-86. PubMed ID: 19108022 [TBL] [Abstract][Full Text] [Related]
15. Histologic heterogeneity predicts patient prognosis of HER2-positive metastatic breast cancer: A retrospective study based on SEER database. Wang Y; Liang Y; Ye F; Luo D; Jin Y; Li Y; Zhao W; Chen B; Wang L; Yang Q Cancer Med; 2023 Sep; 12(18):18597-18610. PubMed ID: 37605516 [TBL] [Abstract][Full Text] [Related]
16. Male breast cancer: A 10 year retrospective case series in a tertiary care hospital. Yetkin G; Celayir MF; Tanik C; Citgez B; Uludag M; Mihmanli M J Pak Med Assoc; 2019 Aug; 69(8):1209-1212. PubMed ID: 31431782 [TBL] [Abstract][Full Text] [Related]
17. Relationship of clinical and pathologic response to neoadjuvant chemotherapy and outcome of locally advanced breast cancer. Gajdos C; Tartter PI; Estabrook A; Gistrak MA; Jaffer S; Bleiweiss IJ J Surg Oncol; 2002 May; 80(1):4-11. PubMed ID: 11967899 [TBL] [Abstract][Full Text] [Related]
18. Clinicopathologic characteristics and survival of male breast cancer. Liu D; Xie G; Chen M Int J Clin Oncol; 2014 Apr; 19(2):280-7. PubMed ID: 23640121 [TBL] [Abstract][Full Text] [Related]
19. Correlation of clinical, pathological status, hormone receptor and C-erbB-2 oncoprotein in breast cancer patients. Aryandono T; Harijadi ; Ghozali A Gan To Kagaku Ryoho; 2000 May; 27 Suppl 2():600-6. PubMed ID: 10895217 [TBL] [Abstract][Full Text] [Related]
20. Overall Survival of Men and Women With Breast Cancer According to Tumor Subtype: A Population-based Study. Leone J; Zwenger AO; Leone BA; Vallejo CT; Leone JP Am J Clin Oncol; 2019 Feb; 42(2):215-220. PubMed ID: 30499840 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]